Firstsource Solutions (FIRSOU) 31



Similar documents
Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Gujarat State Petronet Ltd. INR 135

Quant Picks United Breweries

Wipro Ltd (Wipro) 567

Butterfly Gandhimathi (GANAP) 188

GAIL (India) Ltd. INR 346

Research Analysts. September 30, 2015

Research Analysts. June 30, Lupin LUPIN Buy in the range of

Minda Industries Ltd. INR 886

Gladiator Stocks: Phillips Carbon Black (PHICAR) Time Frame: Six months

Research Analysts. Granules GRANUL Buy in the range of EID Parry EIDPAR Buy in the range of

Bharti Infratel (BHAINF) 370

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015

HCC BUY. Infrastructure January 29, 2016

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015

Khambatta Securities Ltd.

Kotak Mahindra Bank Rs 685

Aban Offshore (ABALLO) 180

Britannia Industries

East India Hotels (EIH) 114

Federal Bank (FEDBAN) 50

GlaxoSmithKline Consumer Healthcare

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Flexituff International Ltd. (FIL)

Navin Fluorine International

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

How To Value Powergrid (India)

Maruti Suzuki. Source: Company Data; PL Research

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

Strong operational performance

Company Overview. Financial Performance

East India Hotels (EIH) 109

The Ramco Cements. Source: Company Data; PL Research

Simplex Infrastructures

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

Pidilite Industries. Source: Company Data; PL Research

Tree House Education & Accessories

Mangalam Cement Weak volumes marred performance

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, Target Price Rs220. IT India.

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

Gail (India) Ltd (GAIL) 305

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Just Dial Ltd Bloomberg Code: JUST IN

Wipro BUY. Performance Highlights CMP. `573 Target Price `719. 2QFY2016 Result Update IT. Investment Period 12 Months. 3-year price chart

Cipla Ltd. Rs India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

Results impacted by subdued demand

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP Target Price SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

Granules India Ltd. INR 113

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

City Union Bank (CITUNI) 87

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

Higher other income drive the quarter

ICICI BANK INR 233. Dismal asset quality performance. Target Price (INR): 314. India Equity Institutional Research BFSI.

Techno Electric & Engineering Limited

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Larsen & Toubro. Source: Company Data; PL Research

UltraTech Cement Ltd.

Jubilant Life Sciences

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

Va Tech Wabag. Source: Company Data; PL Research

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, CRISIL Ltd. Recommendation (Rs.)

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP Target Price JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

Natco Pharma (NATPHA)

Axis Bank INR 521. Target Price (INR): 600. Staunch operating metrics; but blemish asset quality. Potential Upside: 15.16%

India Equity Research Telecommunications September 2, 2015 Management Meet Update

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

Pitti Laminations (PITLAM) 48

Pipavav Defence & Offshore (PIPSHI) 63

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

How To Value Hpl In India

Sphere Global Services Limited

Great Eastern Shipping (GESHIP) 405

Apollo Tyres (APOTYR) 170

VRL Logistics. IPO Review. Price band ICICI Securities Ltd Retail Equity Research

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Apollo Tyres (APOTYR) 169

infotech.com SECTOR: IT SOFTWARE REPORTING DATE: 31 ST MAY, i Infotech Ltd.

RamKrishna Forgings Ltd.

Smruthi Organics Limited BSE Scrip Code:

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

Transcription:

Result Update Rating matrix Rating : Buy Target : 45 Target Period : 12 months Potential Upside : 45% What s changed? Target EPS FY16E EPS FY17E Rating Unchanged Unchanged Unchanged Unchanged Quarterly performance FY16 FY15 YoY (%) FY16 QoQ (%) Revenue 792 774 2.4 747 6.1 EBITDA 98 95 3.7 90 9.7 EBITDA (%) 12.4 12.3 16 bps 12.0 41 bps PAT 62 61 1.0 56 9.6 Key financials Crore FY14 FY15E FY16E FY17E Net Sales 3,106 3,035 3,237 3,501 EBITDA 362 381 431 490 Net Profit 193 234 290 352 EPS ( ) 2.8 3.3 4.2 5.1 Valuation summary FY14 FY15E FY16E FY17E P/E 11.0 9.3 7.4 6.1 Target P/E 16.0 13.5 10.8 8.9 EV / EBITDA 8.0 7.2 5.8 4.4 P/BV 1.0 1.0 0.9 0.8 RoNW (%) 9.2 11.2 12.2 12.9 RoCE (%) 7.7 9.5 11.6 14.1 Stock data Particular Amount Market Capitalization ( Crore) 2,084.1 Total Debt (Sept-15) ( Crore) 719.8 Cash and Investments (Sept-15) ( Crore) 172.3 EV ( Crore) 2,631.6 52 week H/L 42.8 / 24.2 Equity capital 672.3 Face value 10.0 Price performance 1M 3M 6M 12M FSOL 12.2 11.9 17.8 (10.2) HGS 0.6 (8.7) (20.4) (22.1) EXL 9.6 12.8 32.0 30.0 Genpact 2.7 1.2 10.7 23.5 Research Analyst Abhishek Shindadkar abhishek.shindadkar@icicisecurities.com Solid quarter October 30, 2015 Firstsource Solutions (FIRSOU) 31 Firstsource Solutions (FSL) reported strong FY16 earnings, which were in line with our raised estimates Revenues from operations grew 6.1% QoQ to 792.5 crore in line with our 797 crore and 6.7% QoQ growth estimate. Constant currency revenues grew 3.2% QoQ At 12.4%, EBITDA margins improved 41 bps QoQ and were above our 20 bps improvement and 12.2% estimate. Reported PAT of 61.9 crore was also above our 61 crore estimate, led by margin improvement Solid quarter; guidance intact FSL s revenues during the quarter grew 6.1% QoQ (3.2% QoQ in constant currency) led by a recovery in top client (up 16.8% QoQ), absence of revenue leakages led by the US telecom client and domestic business, and growth in telecom & media and healthcare verticals. FSL s management highlighted that a majority of growth concerns are behind them and recent deal wins [closed large transformational deal with UK BFSI client with total contract value (TCV) of ~$170 million over 10 years period, which would contribute $7-8 million in H2FY16) and bookings won deals worth $37 million in annual contract value (ACV) in FY16 taking the total H1FY16 ACV to $61 million ($81 million in H1FY15] could help sustain growth momentum in H2FY16. Margin improvement trajectory may continue in H2FY16E FY16 margins improved 41 bps QoQ and 16 bps YoY to 12.4%, with minimal revenue leakages, operational efficiency and rationalisation of domestic accounts. The management narrowed its EBITDA margin guidance and now expects margin to expand 70-80 bps (70-90 bps earlier) YoY in FY16E led by better margins in new deals, tailwinds from termination of loss-making accounts, acceleration in 1) collections business in Q4 led by seasonality and 2) healthcare and analytics business, partially offset by SG&A investments. Overall, FY15 margins improved 89 bps YoY to 12.5% led by rationalisation of loss making accounts. Top customer recovers sharply Top customer growth rebounded sharply grew 16.8% QoQ vs. 7.2% 7.1% and 6.8% QoQ decline in FY16 and Q4, Q3FY15, respectively. However, revenues are still down 6.2% on YoY basis and contrasts with 25% CAGR reported during FY10-15 and continues to drag company average. Top 2-5 customer revenues grew 3.9% YoY and 7.1% QoQ (vs. - 5.2%, 2.5% respectively in FY16) but is modest compared to 9.4% YoY CAGR achieved during FY10-15. Recovery in top and top 2-5 clients vs. uneven earlier (led by client specific ramp-downs and decision making delays) bodes well for company average growth. Maintaining estimates; target price We estimate FSL will report revenue, earnings CAGR of 4%, 22% over FY15-17E (average 13.7% EBITDA margins in FY16-17E), vs. 9%, 12% reported in FY10-15 (average 11.8%) as recovery in top customer, new deal wins could help growth while focus on margins could yield profitability. We continue to value the stock at 45, i.e. at 6x FY17E EV/EBITDA, modestly below its FY10-15 average of 6.7x, to account for moderating growth and maintain our BUY rating on reasonable valuations. ICICI Securities Ltd Retail Equity Research

Variance analysis FY16 FY16E FY15 YoY (%) FY16 QoQ (%) Comments Revenue 792.5 797.0 774.0 2.4 746.9 6.1 Revenues grew 6.1% QoQ in line with our raised estimates. Constant currency revenues grew 3.2% QoQ Employee expenses 534.2 534.8 520.0 2.7 499.7 6.9 Gross Margin 258.3 262.2 254.0 1.7 247.3 4.5 Gross margin (%) 32.6 32.9 32.8-22 bps 33.1-51 bps SG&A expenses 159.9 164.9 159.1 0.5 157.6 1.4 EBITDA 98.4 97.3 94.9 3.7 89.7 9.7 EBITDA Margin (%) 12.4 12.2 12.3 16 bps 12.0 41 bps Depreciation & amortisation 18.3 18.3 17.7 3.2 17.2 6.4 EBIT 80.1 79.0 77.1 3.8 72.5 10.5 EBIT Margin (%) 10.1 9.9 10.0 14 bps 9.7 41 bps Other income (less interest) -12.1-10.3-13.4-9.8-9.7 25.0 PBT 68.0 68.7 63.8 6.7 62.8 8.3 Tax paid 6.1 7.6 2.5 145.3 6.3-3.1 PAT 61.9 61.0 61.2 1.0 56.4 9.6 EBITDA margins improved 41 bps QoQ above our 20 bps improvement estimate Change in estimates FY16E FY17E ( Crore) Old New % Change Old New % Change Comments Revenue 3,237 3,237 0.0 3,501 3,501 0.0 Management commentary indicates FY16E constant currency revenues could grow 7% EBITDA 431 431 0.0 490 490 0.0 EBITDA Margin (%) 13.3 13.3 0 bps 14.0 14.0 0 bps FY16 EBITDA margin improvement guidance narrowed to 70-80 bps vs. ~70-90 bps earlier PAT 290 290 0.0 352 352 0.0 EPS ( ) 4.2 4.2 0.0 5.1 5.1 0.0 ICICI Securities Ltd Retail Equity Research Page 2

Company Analysis Solid quarter; guidance intact FSL s revenues during the quarter grew 6.1% QoQ (3.2% QoQ in constant currency) led by a recovery in top client (up 16.8% QoQ), absence of revenue leakages led by the US telecom client and domestic business, and growth in telecom & media and healthcare verticals. The FSL management highlighted that a majority of growth concerns are behind them and that recent deals wins (closed large transformational deal with UK BFSI client with total contract value (TCV) of ~$170 million over 10 years period, which would contribute $7-8 million in H2FY16) and bookings won deals worth $ 37 million in annual contract value (ACV) in FY16 taking the total H1FY16 ACV to $61mn ($81 million in H1FY15) could help sustain growth momentum in H2FY16. Finally, the commentary suggests that deals already won provide 4-4.5% YoY growth visibility while the balance (7% YoY FY16E guidance) could be made from another lift-off deal which the company expects to close by December 2015/January 2016. Consequently, we maintain our revenue growth assumption. Recall, FY15 revenues had declined 2.3% YoY led by rationalisation of loss making accounts (including large Irish telecom client) and new deal ramp-ups delays. The management expects $12-15 million revenue headwind from this telco client in FY16E with additional ~$8 million impact from the domestic telco business. Exhibit 1: Rupee revenue may grow at 5% CAGR during FY15-17E 4500 40 crore 3700 2900 2100 1300 25.0 2819 3106 12.7 2255 1971 2055 9.7 10.2 5.1 4.3-2.1-6.1-5.3 756 774 751 754 3237 3501 3035 6.7 8.1 2.4-1.1-2.3 747 792 30 20 10 0 500 FY10 FY11 FY12 FY13 FY14 Q3 Q4 FY15 FY16E FY17E % -10 Rupee revenue Growth, YoY Margin improvement trajectory could continue in H2FY16E FY16 margins improved 41 bps QoQ and 16 bps YoY to 12.4%, with minimal revenue leakages, operational efficiency and rationalisation of domestic accounts. The management narrowed its EBITDA margin guidance and now expect margin to expand 70-80 bps (70-90 bps earlier) YoY in FY16E led by better margins in new deals, tailwinds from termination of loss-making accounts, acceleration in 1) collections business in Q4 led by seasonality, and 2) healthcare and analytics business, partially offset by SG&A investments. Overall, FY15 margins improved 89 bps YoY to 12.5% led by rationalisation of loss making accounts. Recall, FSL s operating margins declined to 8.2% in FY12 vs. 14.2% in FY10 and were impacted by a variety of reasons including rise in delinquencies, investments in India operations, decentralising corporate functions and timing of big acquisitions. ICICI Securities Ltd Retail Equity Research Page 3

Exhibit 2: Modelling margin improvement of ~80 bps YoY in FY16E 20 % 17 14 11 8 14.2 14.1 8.2 9.9 11.7 12.3 12.3 12.5 13.2 12.5 12.0 12.4 13.3 14.0 5 FY10 FY11 FY12 FY13 FY14 Q3 Q4 FY15 FY16E FY17E EBITDA margin Exhibit 3: Growth, headcount rationalisation could drive seat fill factor higher % 85 81 77 73 69 80.0 71.0 74.1 81.8 77.0 73.4 73.1 72.0 69.0 69.0 68.0 66.6 65 FY10 FY11 FY12 FY13 FY14 Q3 Q4 FY15 Seat fill factor Top customer recovers sharply Top customer growth rebounded sharply grew 16.8% QoQ vs. 7.2% 7.1% and 6.8% QoQ decline in FY16 and Q4, Q3FY15, respectively. However, revenues are still down 6.2% on YoY basis and contrasts with 25% CAGR reported during FY10-15 and continues to drag company average. Top 2-5 customer revenues grew 3.9% YoY and 7.1% QoQ (vs. - 5.2%, 2.5% respectively in FY16) but is modest compared to 9.4% YoY CAGR achieved during FY10-15. Recovery in top and top 2-5 clients vs. uneven earlier (led by client specific ramp-downs and decision making delays) bodes well for company average growth. Debt repayment on track As on end, FSL had net long term debt of ~$105 million and cash of ~$26.3 million assuming period ending rates. At the current repayment rate, FSL would repay ~$22.5 million of its debt in the remainder of FY16E and could result in a net debt of ~$82 million assuming current cash levels and no accelerated payments. We estimate the net debt neutral status achievement could likely be achieved in FY17E. ICICI Securities Ltd Retail Equity Research Page 4

Outlook and valuation Firstsource reported strong FY16 earnings, which were in line with our raised estimates. Revenues from operations grew 6.1% QoQ in line with our raised 6.7% QoQ growth estimate. Constant currency revenues grew 3.2% QoQ. Recovery in top, top 2-5 customers and deal momentum bodes well and could help FSL in achieving its 7% constant currency revenue growth and 70-80 bps operating margin improvement guidance in FY16E. We estimate FSL will report revenue, earnings CAGR of 4%, 22% over FY15-17E (average 13.7% EBITDA margins in FY16-17E) vs. 9%, 12% reported during FY10-15 (average 11.8%) as recovery in top customer, new deal wins could help growth while focus on margins could yield profitability. We continue to value the stock at 45, i.e. at 6x FY17E EV/EBITDA, modestly below its FY10-15 average of 6.7x, to account for moderating growth and maintain our BUY rating on reasonable valuations. Exhibit 4: One year forward rolling EV/EBITDA 5000 4000 3000 2000 1000 0 Sep-08 Feb-09 Jul-09 Dec-09 May-10 Oct-10 Mar-11 Aug-11 Jan-12 Jun-12 Nov-12 Apr-13 Sep-13 Feb-14 Jul-14 Dec-14 May-15 Oct-15 EV 10 8 6 4 2 Exhibit 5: Valuations Sales Gr owth EPS Growth PE EV /EBITDA RoNW RoCE ( cr) (%) ( ) (%) (x) (x) ( %) (%) FY14 3,106 10.2 2.8 (0.4) 11.0 8.0 9.2 7.7 FY15 3,035 (2.3) 3.3 18.4 9.3 7.2 11.2 9.5 FY16E 3,237 6.7 4.2 24.8 7.4 5.8 12.2 11.6 FY17E 3,501 8.1 5.1 21.4 6.1 4.4 12.9 14.1 ICICI Securities Ltd Retail Equity Research Page 5

Company snapshot 60 50 Target price : 45 40 30 20 10 0 Jan-10 Apr-10 Jul-10 Oct-10 Jan-11 Apr-11 Jul-11 Oct-11 Jan-12 Apr-12 Jul-12 Oct-12 Jan-13 Apr-13 Jul-13 Oct-13 Jan-14 Apr-14 Jul-14 Oct-14 Jan-15 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Source: Bloomberg, Company, ICICIdirect.com Research Key events Date Event Feb-11 FSOL approves merger of unit Revit Systems with itself Dec-11 The stock hits all-time low as it reports lowest net profit since FY09 and lowest ever net profit on annualised basis since FY08 Dec-12 RPG led CESC acquires 56% stake in the company. Repays FCCB obligation worth $ 237 million in December 2012. Jan-13 CESC-controlled Spen Liq Ltd tenders an open offer to acquire additional stake in the company at 12.2 per share Jul-13 Rakesh Jhunjhunwala buys 5.14% stake in the company at an average 10 per share Dec-13 The company successfully makes its third quarterly principal repayment of $11.25 million on its outstanding debt on December 31, 2013 Mar-14 The company successfully makes its fourth quarterly principal repayment of $11.25 million on its outstanding debt on March 31, 2014 The company reports in line quarter with 174 bps margin expansion for FY14 led by exiting lower margin domestic business. It reduces FY15E growth outlook to 6% Apr-14 from 8% earlier. Nov-14 FSL reports moderate growth during FY15 with 94 bps YoY margin expansion. However, it lowers its FY15E guidance to 2-2.5% vs. 6% earlier May-15 Reports weak Q4FY15 earnings as revenues, absolute EBITDA and PAT were below our estimates Jun-15 Firstsource reports soft FY16 earnings. Though revenues were above our estimates, absolute EBITDA and PAT were below Reports strong FY16 earnings, which were in line with our raised estimates.revenues from operations grew 6.1% QoQ while constant currency revenues grew Oct-15 3.2% QoQ Top 10 Shareholders Rank Name Latest Filing Date % O/S Position (m) Change (m) 1 RPG Enterprises 30-Sep-15 55.79 374.0 0.0 2 ICICI Group 30-Sep-15 4.80 32.2 0.0 3 Jhunjhunwala (Rakesh) 30-Sep-15 3.73 25.0 0.0 4 Goldman Sachs Asset Management International 30-Sep-15 2.76 18.5 0.3 5 Deutsche Asset Management (India) Private Ltd. 30-Jun-15 2.50 16.7 0.1 6 Birla Sun Life Asset Management Company Ltd. 30-Sep-15 1.81 12.2 3.2 7 Steinberg Asset Management, LLC 30-Sep-15 1.46 9.8 9.8 8 Dimensional Fund Advisors, L.P. 31-Aug-15 1.41 9.4 0.0 9 Principal PNB Asset Management Company Ltd. 30-Sep-15 0.46 3.1 0.3 10 Subramaniam (Rajesh) 2-Sep-15 0.26 1.8 1.3 Source: Reuters, ICICIdirect.com Research Shareholding Pattern (in %) Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 Promoter 56.41 56.23 56.13 56.08 55.79 FII 7.88 8.25 9.13 9.84 9.10 DII 7.19 7.28 6.72 6.80 7.34 Others 28.52 28.24 28.02 27.28 27.77 Recent Activity Buys Sells Investor name Value Shares Investor name Value Shares Steinberg Asset Management, LLC 3.94m 9.78m DSP BlackRock Investment Managers Pvt. Ltd. -2.01m -3.89m Birla Sun Life Asset Management Company Ltd. 1.30m 3.23m Mellon Capital Management Corporation -0.67m -1.66m Subramaniam (Rajesh) 0.50m 1.25m Pramerica Asset Managers Pvt. Ltd. -0.36m -0.55m Principal PNB Asset Management Company Ltd. 0.10m 0.25m Harding Loevner LP -0.27m -0.52m Ponnappa (K M) 0.10m 0.24m ICICI Securities Ltd Retail Equity Research Page 6

Financial summary Profit and loss statement Crore FY14 FY15E FY16E FY17E Total Revenues 3,106 3,035 3,237 3,501 Growth (%) 10.2 (2.3) 6.7 8.1 Employee expenses 2,129 2,018 2,143 2,310 Other Expenses 614 636 664 700 EBITDA 362 381 431 490 Growth (%) 29.5 5.1 13.1 13.8 Depreciation & Amortization 76 72 74 77 Other Income 1 2 4 9 Interest 84 67 41 25 PBT before Exceptional Items 203 244 319 396 Growth (%) 27.7 20.0 30.8 24.2 Tax 10 10 29 44 PAT before Exceptional Items 193 234 290 352 Exeptional items - - - - PAT before MI 193 234 290 352 Minority Int & Pft. from associates 0 0 0 0 PAT 193 234 290 352 Growth (%) 31.6 21.4 23.8 21.4 EPS 2.8 3.3 4.2 5.1 EPS (Growth %) (0.4) 18.4 24.8 21.4 Cash flow statement Crore FY14 FY15E FY16E FY17E Profit before Tax 203 244 319 396 Depreciation & Amortization 76 72 74 77 WC changes 125 (105) 26 (5) Other non cash adju. 34 86 37 16 CF from operations 396 246 427 441 Capital expenditure (36) (46) (115) (75) Δ in investments (2) (62) - - Other investing cash flow 24 4 4 9 CF from investing Activities (13) (104) (111) (66) Issue of equity 3 11 - - Δ in debt funds (209) (213) (270) (270) Dividends paid - - - - Other financing cash flow (80) (44) (41) (25) CF from Financial Activities (286) (246) (311) (295) Δ in cash and cash bank balance 96 (105) 5 80 Effect of exchange rate changes - - - - Opening cash 89 185 80 86 Closing cash 185 80 86 165 Balance sheet Crore FY14 FY15E FY16E FY17E Equity 660 666 666 666 Reserves & Surplus 1,432 1,422 1,712 2,064 Networth 2,091 2,089 2,379 2,731 Minority Interest 1 2 2 2 LT liabilties & provisions 736 467 267 67 Source of funds 2,829 2,557 2,647 2,799 Net fixed assets 137 119 159 157 Goodwill 2,594 2,334 2,334 2,334 Other non current assets 211 231 231 231 Loans and advances 41 29 29 31 Current Investments 3 68 68 68 Debtors 302 289 299 323 Cash & Cash equivalents 186 80 86 165 Other current assets 216 278 286 305 Short term borrowings 246 316 246 176 Trade payables 113 93 100 108 Current liabilities 483 447 482 514 Provisions 19 14 16 17 Application of funds 2,829 2,557 2,647 2,799 Key ratios (Year-end March) FY14 FY15E FY16E FY17E Per share data ( ) EPS-diluted 2.8 3.3 4.2 5.1 Cash per share 2.7 1.1 1.2 2.4 BV 30.6 29.8 34.2 39.3 Operating profit per share 4.3 4.6 5.3 6.1 Operating Ratios (%) EBITDA Margin 11.7 12.5 13.3 14.0 PBT Margin 6.5 8.0 9.9 11.3 PAT Margin 6.2 7.7 9.0 10.1 Return Ratios (%) RoNW 9.2 11.2 12.2 12.9 RoCE 7.7 9.5 11.6 14.1 Valuation Ratios (x) P/E 11.0 9.3 7.4 6.1 EV / EBITDA 8.0 7.2 5.8 4.4 Price to Book Value 1.0 1.0 0.9 0.8 EV / Net Sales 0.9 0.9 0.8 0.6 Mcap / Net Sales 0.7 0.7 0.7 0.6 Turnover Ratios Debtor days 35 35 34 34 Creditors days 13 11 11 11 Solvency Ratios Total Debt / Equity 0.4 0.3 0.2 0.1 Current Ratio 0.9 1.1 1.0 1.0 Quick Ratio 0.9 1.1 1.0 1.0 Debt / EBITDA 2.5 1.9 1.1 0.4. ICICI Securities Ltd Retail Equity Research Page 7

ICICIdirect.com coverage universe (IT) CMP M Cap EPS ( ) P/E (x) EV/EBITDA (x) RoCE (%) RoE (%) Sector / Company ( ) TP( ) Rating ( Cr) FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E Cyient (INFENT) 542 500 Hold 6,092 31.4 34.0 40.0 17.3 15.9 13.5 13.5 11.0 8.6 22.2 21.9 22.4 19.2 18.1 18.6 Eclerx (ECLSER) 1,865 1,500 Sell 5,686 74.3 99.0 110.0 25.1 18.8 17.0 15.1 11.7 9.9 40.4 45.8 43.5 32.1 35.5 33.2 Firstsource (FIRSOU) 32 45 Buy 2,165 3.3 4.2 5.1 9.7 7.7 6.4 7.2 5.8 4.4 9.5 11.6 14.1 11.2 12.2 12.9 HCL Tech* (HCLTEC) 873 1,050 Buy 122,744 51.4 55.0 64.0 17.0 15.9 13.6 12.5 11.0 9.0 35.2 31.7 30.5 29.3 25.7 24.7 Infosys (INFTEC) 1,136 1,300 Buy 260,818 53.9 57.0 65.0 21.0 19.9 17.5 14.9 13.4 11.4 31.4 29.7 30.1 22.5 21.3 21.7 KPIT Tech (KPISYS) 137 135 Hold 2,703 11.9 12.5 14.0 11.6 11.0 9.8 8.3 6.6 5.6 14.7 17.4 17.4 17.0 15.4 14.9 Mindtree (MINCON) 1,568 1,600 Hold 13,143 63.9 75.0 96.0 24.5 20.9 16.3 17.0 14.0 11.2 33.7 32.9 34.3 26.6 25.9 26.9 NIIT Technologies (NIITEC) 595 525 Hold 3,634 31.8 42.0 47.5 18.7 14.2 12.5 8.2 5.9 4.9 23.4 29.8 31.9 14.3 16.6 16.6 o Persistent (PSYS) 646 675 Hold 5,170 36.3 41.0 48.0 17.8 15.8 13.5 11.2 9.0 7.2 27.5 26.6 26.6 20.7 19.7 19.5 TCS (TCS) 2,499 2,800 Buy 492,410 110.8 119.0 130.0 22.6 21.0 19.2 17.2 15.2 13.4 81.8 77.3 74.6 42.8 36.1 31.9 Tech Mahindra (TECMAH) 541 600 Buy 52,223 26.7 29.0 36.0 20.2 18.6 15.0 11.8 11.6 9.3 26.9 24.9 26.5 21.5 19.4 20.4 Wipro (WIPRO) 572 680 Buy 141,170 35.1 37.0 40.5 16.3 15.4 14.1 11.6 10.4 9.1 23.0 22.6 22.4 21.2 19.7 19.1 * June year end, ICICI Securities Ltd Retail Equity Research Page 8

RATING RATIONALE ICICIdirect.com endeavours to provide objective opinions and recommendations. ICICIdirect.com assigns ratings to its stocks according to their notional target price vs. current market price and then categorises them as Strong Buy, Buy, Hold and Sell. The performance horizon is two years unless specified and the notional target price is defined as the analysts' valuation for a stock. Strong Buy: >15%/20% for large caps/midcaps, respectively, with high conviction; Buy: >10%/15% for large caps/midcaps, respectively; Hold: Up to +/-10%; Sell: -10% or more; Pankaj Pandey Head Research pankaj.pandey@icicisecurities.com ICICIdirect.com Research Desk, ICICI Securities Limited, 1st Floor, Akruti Trade Centre, Road No 7, MIDC, Andheri (East) Mumbai 400 093 research@icicidirect.com ICICI Securities Ltd Retail Equity Research Page 9

ANALYST CERTIFICATION We /I, Abhishek Shindadkar, MBA, Research Analyst, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: ICICI Securities Limited (ICICI Securities) is a Sebi registered Research Analyst having registration no. INH000000990. ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial products. ICICI Securities is a wholly-owned subsidiary of ICICI Bank which is India s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. ( associates ), the details in respect of which are available on www.icicibank.com ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction. ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the companies mentioned in the report in the past twelve months. ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts have any material conflict of interest at the time of publication of this report. It is confirmed that Abhishek Shindadkar, MBA, Research Analyst of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ICICI Securities or its subsidiaries collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report. Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. It is confirmed that Abhishek Shindadkar, MBA, Research Analyst do not serve as an officer, director or employee of the companies mentioned in the report. ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report. We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. ICICI Securities Ltd Retail Equity Research Page 10